"On December 21, the U.S. Food and Drug Administration approved Uptravi (selexipag) tablets to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive, and debilitating rare lung disease that can lead to death or the need f"...
No information provided. Please refer to the WARNINGS AND PRECAUTIONS section.
Last reviewed on RxList: 10/26/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Inomax Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.